Optimal Treatment of Miscarriage
This trial is active, not recruiting.
|Start date||October 2008|
|End date||December 2015|
|Trial size||190 participants|
|Trial identifier||NCT01033903, EudraCT 2007-007661-20|
The main objective of the study is to determine if there is a difference in the number of women with a complete miscarriage after 10 days between expectant management versus treatment with 800 micrograms of misoprostol intravaginally in women with an an incomplete miscarriage before 14 weeks and a gestational sac retained in the uterus.
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
time frame: 10 days
time frame: 17 days, 24 days, 31 days
Female participants at least 18 years old.
Inclusion Criteria: - nonviable intrauterine pregnancy with retained gestational sac in the uterus - the embryo if visible 5 to 35 mm without a heart beat - vaginal bleeding - circulatory stable - hemoglobin at least 80 g/L Exclusion Criteria: - contraindications against misoprostol
|Official title||Which is the Optimal Treatment for Miscarriage With a Gestational ac in the Uterus and Which Factors Can Predict if the Treatment Will be Successful?|
Call for more information